Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Retraction Note | Open | Published:

Retraction Note: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients

The original article was published in European Journal of Medical Research 2014 19:50

Retraction

The Publisher and Editor regretfully retract this article [1] because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.

Reference

  1. 1.

    Luo Y, Li Z, Cui S, Shen C, Zhao J, Wu M, et al. Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. Eur J Med Res. 2014;19:50.

Download references

Author information

Correspondence to Zhanquan Li or Ge Ri-li.

Additional information

The online version of the original article can be found under doi:10.1186/s40001-014-0050-z.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark